Join        Login             Stock Quote

PSS World Medical (PSSI): A Good Investment Play In Healthcare Distribution Sector

 May 29, 2012 03:24 PM

(By Mani) PSS World Medical Inc. (NASDAQ:PSSI) is set to be a virtual pure-play physician office medical distributor following the announcement to divest its slower-growth, nursing home distribution business.

Jacksonville, Florida-based, PSS World Medical distributes medical and surgical supplies solely within the United States, primarily to office-based physicians and skilled nursing, hospice and home healthcare facilities.

Following recent quarterly results that were somewhat disappointing relative to expectations, shares of PSS are now down 19 percent year-to-date, making PSS one of the worst performing stocks within the entire healthcare distribution sector, which is up 13 percent year-to-date overall. However, shares have about 35 percent upside potential from current levels.

[Related -Medical Supply Stocks To Get Hit By The Taxman, Yeah, The Taxman]

Overall, the company's physician business has generated better organic growth for the company over the past several years, while the Eldercare business has been weaker due primarily to sluggish results in the nursing home segment.

Since the company has decided to exit nursing home business, it would allow for more rapid growth over the next several years from the remaining faster growth businesses within the company.

PSS has done a good job of managing through the economic downturn over the past few years by cutting costs while still retaining a full sales force to supplement declining volumes with new customers. The core physician distribution remains steady with the exception of tough flu comps this past quarter.

[Related -Stocks End Modestly Higher amid Domestic Data, Earnings; Synaptics (SYNA) Jumps]

Specifically, the company will focus on physician, laboratory, in-office dispensing, and the home care and hospice markets. Once the EPS base is "reset," PSS should generate faster EPS growth over the next few years.

"With the associated downdraft in the stock in relation to the moving parts around the restructuring, we see an excellent entry point into the stock," UBS analyst Steven Valiquette wrote in a note to clients.

Meanwhile, the company's growth in the North American physician office distribution business has been consistently robust with the overall scope of healthcare. PSS witnessed a nice recovery in 2011, and is expected to deliver robust growth in 2012-2014, as well.

The analyst expects PSS will able to generate more rapid growth in the fiscal 2014- 2017 period without the anchor of the slower-growth, nursing home distribution business. PSS is also expected to pursue acquisitions aggressively in the short-term with the proceeds from the asset sales.

iOnTheMarket Premium


5/30/2012 7:23:45 AM
Shares will bounce back by sofia
I am having trust in this company , itss share are going to definetly bounce back, right time to buy now.
Rating: (0) (0)
Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageInitial Jobless Claims Rose Unexpectedly

Claims unexpectedly rose in the latest report through last weekend to breach 300,000 for the first time read on...

article imageAll Quiet on the Record High Front

What can we glean from the media’s lack of attention to the market’s recent record read on...

article imageThe Chip Maker Short Sellers Should Be Watching

Investing in semiconductor stocks is always tricky. Industry cycles can lead to bumps in the road for the read on...

article imageChicago Fed: US Economic Growth Slowed In October

The pace of US growth slowed more than expected in October, according to this morning’s update of the read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.